Press release
The Cushing’s Disease Treatment Market to grow at an invigorating pace in the next decade
Cushing disease is caused by tumour in the pituitary gland which leads to excessive secretion of a hormone called adrenocorticotrophic (ACTH), which in turn leads to increasing levels of cortisol in the body. Cortisol is a steroid hormone released by the adrenal glands and helps the body to deal with injury or infection. Increasing levels of cortisol increases the blood sugar and can even cause diabetes mellitus. However the disease is also caused due to excess production of hypothalamus corticotropin releasing hormone (CRH) which stimulates the synthesis of cortisol by the adrenal glands. The condition is named after Harvey Cushing, the doctor who first identified the disease in 1912. Cushing disease results in Cushing syndrome. Cushing syndrome is a group of signs and symptoms developed due to prolonged exposure to cortisol. Signs and symptoms of Cushing syndrome includes hypertension, abdominal obesity, muscle weakness, headache, fragile skin, acne, thin arms and legs, red stretch marks on stomach, fluid retention or swelling, excess body and facial hair, weight gain, acne, buffalo hump, tiredness, fatigue, brittle bones, low back pain, moon shaped face etc. Symptoms vary from individual to individual depending upon the disease duration, age and gender of the patient. Disease diagnosis is done by measuring levels of cortisol in patient’s urine, saliva or blood. For confirming the diagnosis, a blood test for ACTH is performed. The first-line treatment of the disease is through surgical resection of ACTH-secreting pituitary adenoma, however disease management is also done through medications, Cushing disease treatment market comprises of the drugs designed for lowering the level of cortisol in the body. Thus patients suffering from Cushing disease are prescribed medications such as ketoconazole, mitotane, aminoglutethimide metyrapone, mifepristone, etomidate and pasireotide.Cushing’s disease treatment market revenue is growing with a stable growth rate, this is attributed to increasing number of pipeline drugs. Also increasing interest of pharmaceutical companies to develop Cushing disease drugs is a major factor contributing to the revenue growth of Cushing disease treatment market over the forecast period. Current and emerging players’ focuses on physician education and awareness regarding availability of different drugs for curing Cushing disease, thus increasing the referral speeds, time to diagnosis and volume of diagnosed Cushing disease individuals. Growing healthcare expenditure and increasing awareness regarding Cushing syndrome aids in the revenue growth of Cushing’s disease treatment market. Increasing number of new product launches also drives the market for Cushing’s disease Treatment devices. However availability of alternative therapies for curing Cushing syndrome is expected to hamper the growth of the Cushing’s disease treatment market over the forecast period.
To remain ‘ahead’ of your competitors, request for a sample here@
https://www.persistencemarketresearch.com/samples/14155
The Cushing’s disease Treatment market is segment based on the product type, technology type and end user
Cushing’s disease Treatment market is segmented into following types:
By Drug Type
Ketoconazole
Mitotane
Aminoglutethimide
Metyrapone
Mifepristone
Etomidate
Pasireotide
By End User
Hospital Pharmacies
Retail Pharmacies
Drug Stores
Clinics
e-Commerce/Online Pharmacies
Cushing’s disease treatment market revenue is expected to grow at a good growth rate, over the forecast period. The market is anticipated to perform well in the near future due to increasing awareness regarding the condition. Also the market is anticipated to grow with a fastest CAGR over the forecast period, attributed to increasing investment in R&D and increasing number of new product launches which is estimated to drive the revenue growth of Cushing’s disease treatment market over the forecast period.
To receive extensive list of important regions, Request Methodology here @
https://www.persistencemarketresearch.com/methodology/14155
Depending on geographic region, the Cushing’s disease treatment market is segmented into five key regions: North America, Latin America, Europe, Asia Pacific (APAC) and Middle East & Africa (MEA).
North America is occupying the largest regional market share in the global Cushing’s disease treatment market owing to the presence of more number of market players, high awareness levels regarding Cushing syndrome. Healthcare expenditure and relatively larger number of R&D exercises pertaining to drug manufacturing and marketing activities in the region. Also Europe is expected to perform well in the near future due to increasing prevalence of the condition in the region.
Asia Pacific is expected to grow at the fastest CAGR because of increase in the number of people showing the symptoms of Cushing syndrome, thus boosting the market growth of Cushing’s disease treatment market throughout the forecast period.
Some players of Cushing’s disease Treatment market includes CORCEPT THERAPEUTICS, HRA Pharma, Strongbridge Biopharma plc, Novartis AG, etc. However there are numerous companies producing branded generics for Cushing disease. The companies in Cushing’s disease treatment market are increasingly engaged in strategic partnerships, collaborations and promotional activities to capture a greater pie of market share.
You Can Request for TOC Here @
https://www.persistencemarketresearch.com/toc/14155
Naved Beg
Persistence Market Research
Address – 305 Broadway, 7th Floor New York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com
Persistence Market Research, as a 3rd-party research organization, does operate through an exclusive amalgamation of market research and data analytics for helping businesses ride high, irrespective of the turbulence faced on the account of financial/natural crunches.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release The Cushing’s Disease Treatment Market to grow at an invigorating pace in the next decade here
News-ID: 2249830 • Views: …
More Releases from Persistence Market Research

Indian Used Car Industry Set to Grow from US$32.9 Bn in 2025 to US$90.2 Bn by 20 …
The India used car market is poised for significant expansion over the next decade. With a market size of USD 32.9 billion in 2025, it is projected to grow to USD 90.2 billion by 2032, reflecting a robust compound annual growth rate (CAGR) of 15.5% from 2025 to 2032. The market's growth is attributed to increasing consumer demand, improved financing options, and the rising adoption of technology-enabled solutions, which are…

North America Postal Services Market 2025-2032: Insights on Leading Companies Su …
The North America postal services market, currently valued at approximately US$ 88.7 billion in 2025, is projected to witness steady growth, reaching a market size of US$ 96.7 billion by 2032. This growth is expected to occur at a compound annual growth rate (CAGR) of 1.3% during the forecast period from 2025 to 2032, according to the latest report from Persistence Market Research.
Several key factors are driving this growth, notably…

Pneumatic Tire Market Fueled by EV Growth and Mobility Trends to Reach US$517.8 …
The global pneumatic tire market, valued at approximately US$ 377.9 billion in 2025, is projected to experience robust growth over the coming years, with a forecasted value of US$ 517.8 billion by 2032. The market is expected to grow at a compound annual growth rate (CAGR) of 4.6% during the period from 2025 to 2032, according to the latest research report by Persistence Market Research. The increasing demand for pneumatic…

Low Speed Vehicles Market Forecast to Hit US$19.2 Bn by 2032, Recording 6.2% CAG …
The global low-speed vehicles (LSV) market is poised for significant growth, with a projected market size of US$12.6 billion in 2025. This market is expected to reach US$19.2 billion by 2032, growing at a compound annual growth rate (CAGR) of 6.2% during the forecast period from 2025 to 2032. The increasing demand for eco-friendly, cost-efficient, and versatile transport solutions is propelling this growth, particularly in controlled environments such as golf…
More Releases for Cushing
Cushing Syndrome Market Trends is Electrifying Growth Cycle: Bristol Myers Squib …
The latest study released on the Global Cushing Syndrome Market by HTF MI Research evaluates market size, trend, and forecast to 2031. The Cushing Syndrome market study covers significant research data and proofs to be a handy resource document for managers, analysts, industry experts and other key people to have ready-to-access and self-analysed study to help understand market trends, growth drivers, opportunities and upcoming challenges and about the competitors.
Key Players…
Cushing Syndrome Pipeline Appears Robust With 4+ Key Pharma Companies Actively W …
DelveInsight's, "Cushing Syndrome Pipeline Insight, 2025" report provides comprehensive insights about 4+ companies and 4+ pipeline drugs in Cushing Syndrome pipeline landscape. It covers the Cushing Syndrome pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Cushing Syndrome therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore our latest breakthroughs in Cushing Syndrome…
Cushing Syndrome Market Is Booming So Rapidly | Recordati, Diurnal Group, Pfizer
The Global Cushing Syndrome Market Size is estimated at $1.4 Billion in 2025 and is forecast to register an annual growth rate (CAGR) of 22.6% to reach $8.8 Billion by 2034.
The latest study released on the Global Cushing Syndrome Market by USD Analytics Market evaluates market size, trend, and forecast to 2034. The Cushing Syndrome market study covers significant research data and proofs to be a handy resource document for…
Somatostatin Analogs Market Report 2018: Segmentation by Product (Octreotide, La …
Global Somatostatin Analogs market research report provides company profile for Chiasma, Ipsen Biopharmaceutical, Novartis, Peptron and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year 2018 to 2025, etc. The report also provides detailed segmentation on the basis of…
Cushing’s Disease Treatment Market Forecast over 2017 – 2025
Cushing disease is caused by tumour in the pituitary gland which leads to excessive secretion of a hormone called adrenocorticotrophic (ACTH), which in turn leads to increasing levels of cortisol in the body. Cortisol is a steroid hormone released by the adrenal glands and helps the body to deal with injury or infection. Increasing levels of cortisol increases the blood sugar and can even cause diabetes mellitus. However the disease…
Oil Storage Market, Palm Oil Storage and Marketing, Capacity, Cushing Inventory, …
The global oil storage market is segmented based on material, fuel, product, and geography. Based on material, the market is categorized into steel, carbon steel, fiberglass reinforced plastic, and others. By fuel, it is classified into crude oil, gasoline, aviation fuel, middle distillates, liquefied natural gas (LNG), and liquefied petroleum gas (LPG). Based on product, the market is divided into open top, fixed roof, and floating roof. Geographic breakdown and…